Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Changmao Biochemical Engineering Co's Return-on-Tangible-Equity or its related term are showing as below:
HKSE:00954'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -14.73 Med: 4.31 Max: 12.12
Current: -9.13
During the past 13 years, Changmao Biochemical Engineering Co's highest Return-on-Tangible-Equity was 12.12%. The lowest was -14.73%. And the median was 4.31%.
HKSE:00954's Return-on-Tangible-Equity is ranked worse than 87.38% of 1577
companies
in the Chemicals industry
Industry Median: 6.96
vs HKSE:00954: -9.13
Changmao Biochemical Engineering Co (HKSE:00954) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Changmao Biochemical Engineering Co Return-on-Tangible-Equity Related Terms
Changmao Biochemical Engineering Co Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Changmao Biochemical Engineering Co Return-on-Tangible-Equity Chart
HKSE:00954 vs LIN, SHW, ECL: Return-on-Tangible-Equity Comparison
For the Specialty Chemicals subindustry, Changmao Biochemical Engineering Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Changmao Biochemical Engineering Co Return-on-Tangible-Equity vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Changmao Biochemical Engineering Co's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Changmao Biochemical Engineering Co's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Jun. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of -2.14% mean?
Changmao Biochemical Engineering Co (HKSE:00954) has a Return-on-Tangible-Equity of -2.14% as of Jun. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Changmao Biochemical Engineering Co and its competitors. According to the industry distribution chart, Changmao Biochemical Engineering Co ranks #1378 out of 1577 companies in the Chemicals industry, placing it in the top 87.4%.
Is Changmao Biochemical Engineering Co's Return-on-Tangible-Equity too high?
Changmao Biochemical Engineering Co's current Return-on-Tangible-Equity is -2.14%. Based on the distribution chart, Changmao Biochemical Engineering Co ranks #1378 out of 1577 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Changmao Biochemical Engineering Co has a GF Score™ of 34/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Changmao Biochemical Engineering Co's Return-on-Tangible-Equity compare to LIN and SHW?
According to the Chemicals industry distribution chart, Changmao Biochemical Engineering Co ranks #1378 out of 1577 companies for Return-on-Tangible-Equity. This places Changmao Biochemical Engineering Co in the lower half of its industry. The industry median Return-on-Tangible-Equity is 6.96. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Chemicals company?
The median Return-on-Tangible-Equity among Chemicals companies is 6.96, based on 1,577 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Changmao Biochemical Engineering Co and its competitors. For the Chemicals industry, the median Return-on-Tangible-Equity is 6.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Changmao Biochemical Engineering Co's current Return-on-Tangible-Equity is -2.14%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Changmao Biochemical Engineering Co stock overvalued right now?
Based on GuruFocus' analysis, Changmao Biochemical Engineering Co (HKSE:00954) is currently considered Possible Value Trap. The stock's GF Value™ is HK$0.36, compared to a current price of HK$0.22 — trading 39.4% below its estimated fair value. The current Return-on-Tangible-Equity is -2.14%. Changmao Biochemical Engineering Co's overall GF Score™ is 34/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Changmao Biochemical Engineering Co (HKSE:00954), the current Return-on-Tangible-Equity is -2.14% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Changmao Biochemical Engineering Co (HKSE:00954) Overvalued in 2026?
Based on GuruFocus' analysis, Changmao Biochemical Engineering Co stock appears to be undervalued.
The current stock price of HK$0.22 is trading 39.4% below its estimated GF Value™ of HK$0.36.
GuruFocus considers Changmao Biochemical Engineering Co to be Possible Value Trap.
Key valuation signals for HKSE:00954:
Return-on-Tangible-Equity: -2.14%
GF Value™: HK$0.36 vs. price of HK$0.22 (39.4% below fair value)
No single metric tells the full story. See the HKSE:00954 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Changmao Biochemical Engineering Co Ltd is an organic acid producer in the PRC. It produces organic acids products for sale to the food additive, chemical, and pharmaceutical industries. Its products are organic acids and their derivatives with four carbons in their structures including fumaric acid, maleic acid, L-malic acid, D-malic acid, DL-malic acid, L(+)-tartaric acid, D(-)-tartaric acid, DL-tartaric acid, L-aspartic acid, and aspartame. These products are used as food additives or medical intermediaries. Its products are produced along vertical production chains. Its geographic locations include Mainland China, Europe includes Great Britain, Germany, Turkey, Spain, and Italy, Asia Pacific includes Hong Kong, Indonesia, Australia, India, Thailand and Japan, America, and Others.
34GF Score
Get the complete analysis for HKSE:00954
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00954 has been successfully added to your 
